Tenax Therapeutics, Inc. (TENX) financial statements (2021 and earlier)

Company profile

Business Address ONE COPLEY PARKWAY
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
4/30/2015
4/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments75138131758
Cash and cash equivalents6512210858
Short-term investments000639 
Receivables   0000
Prepaid expense0100000
Other current assets     00
Total current assets:76138141859
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0000000
Long-term investments and receivables   2931 
Long-term investments   2931 
Intangible assets, net (including goodwill)     3334
Goodwill     1111
Intangible assets, net (excluding goodwill)     2223
Other noncurrent assets0000110
Other undisclosed noncurrent assets      0
Total noncurrent assets:0002106534
TOTAL ASSETS:761310238393
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2321641
Accounts payable1211110
Accrued liabilities1110531
Debt0    00
Other undisclosed current liabilities   0011
Total current liabilities:2321653
Noncurrent Liabilities
Long-term debt and lease obligation00     
Long-term debt, excluding current maturities0      
Operating lease, liability 0
Liabilities, other than long-term debt      0
Other liabilities      0
Other undisclosed noncurrent liabilities     88
Total noncurrent liabilities:00   88
Total liabilities:232161211
Stockholders' equity
Stockholders' equity attributable to parent, including:54129177083
Common stock0000000
Additional paid in capital251240240222222221219
Accumulated other comprehensive income (loss)(0)00(0)(0)0 
Accumulated deficit(246)(236)(228)(213)(205)(151)(137)
Warrants and rights outstanding     0 
Other undisclosed stockholders' equity attributable to parent 00  (0) 
Total stockholders' equity:54129177083
TOTAL LIABILITIES AND EQUITY:761310238393

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
4/30/2015
4/30/2014
Revenues     00
Revenue, net  00
Cost of revenue
(Cost of Goods and Services Sold)
      (0)
Other undisclosed gross profit      (0)
Gross profit:     0(0)
Operating expenses(10)(9)(7)(9)(53)(15)(17)
Other undisclosed operating income      0
Operating loss:(10)(9)(7)(9)(53)(15)(17)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
000011(1)
Interest and debt expense(0)    (0)(2)
Loss from continuing operations before income taxes:(10)(8)(7)(9)(52)(14)(20)
Income tax benefit    8  
Net loss:(10)(8)(7)(9)(44)(14)(20)
Other undisclosed net loss attributable to parent  (7)    
Net loss attributable to parent:(10)(8)(14)(9)(44)(14)(20)
Preferred stock dividends and other adjustments      (6)
Other undisclosed net income available to common stockholders, basic    882851
Net income (loss) available to common stockholders, basic:(10)(8)(14)(9)441425
Other undisclosed net loss available to common stockholders, diluted     (28)(51)
Net income (loss) available to common stockholders, diluted:(10)(8)(14)(9)44(14)(25)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
4/30/2015
4/30/2014
Net loss:(10)(8)(7)(9)(44)(14)(20)
Comprehensive loss:(10)(8)(7)(9)(44)(14)(20)
Other undisclosed comprehensive income, net of tax, attributable to parent201721188828 
Comprehensive income (loss), net of tax, attributable to parent:1081494414(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: